Please login to the form below

Not currently logged in
Email:
Password:

Gossamer Bio

This page shows the latest Gossamer Bio news and features for those working in and with pharma, biotech and healthcare.

Novartis ditches oral asthma drug after disappointing phase 3 readout

Novartis ditches oral asthma drug after disappointing phase 3 readout

The failure of Novartis’ drug also damages the overall hypothesis of DP2 targeting drug candidates, and particularly hurts the prospects of would-be competitor Gossamer Bio. ... If it can disprove the naysayers and bring GB001 to market in asthma,

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...